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Abstract
Background: There is a shortage of medical specialists within the provincial departments of health in South Africa. Telemedicine is 
a potential way of providing specialist services, at a distance, to rural areas. This study assesses patient and staff satisfaction and 
issues, technological and operational, associated with the establishment of a videoconference-based teledermatology service.
Methods: An ISDN-based videoconference link was established between Port Shepstone Hospital and the Nelson R Mandela School 
of Medicine in Durban. Patients with a dermatological problem that would have necessitated transfer to the academic hospital for 
diagnosis and/or management were entered into a prospective study which evaluated the ability to make a diagnosis and prescribe 
a management plan by videoconference and the patients’ and doctors’ satisfaction with the consultations. 
Results: A total of 69 patients were seen during 12 videoconferenced consultation sessions. Seventeen patients (24.6%) were 
subsequently referred to the academic hospital: nine patients were sent because a definitive diagnosis could not be made; and 
eight patients were transferred for specialist management based on the diagnosis made. The patients’ and referring doctors’ 
satisfaction with the consultation was 80.3% and 82.1% respectively, while the dermatologist was satisfied 67.6% of the time. 
The dermatologist was dissatisfied with ten (14.7%) of the consultations and this was related to difficulties in making a definitive 
diagnosis. The referring doctors found 59 (85.9%) of the consultations to be of educational value.  No problems were noted in 
diagnosing lesions in dark-skinned patients. 
Conclusion: Videoconferenced teledermatology between district hospitals and regional hospitals is possible and can improve services 
to rural areas. Further studies on widespread implementation and sustainability are warranted. 
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Introduction
As in the rest of sub-Saharan Africa, South Africa faces a shortage of 
medical practitioners. This is especially so in the government sector. 
KwaZulu-Natal has a population of 9.4 million people, 53% of whom 
live in rural areas. A large number of medical specialist posts are 
unfilled with only 6.3 specialists, across all disciplines, per 100 000 
uninsured people in the province.1 The dilemma is how to provide an 
acceptable specialist clinical service to all the people. 
Dermatology is a typical example of a speciality with limited resources 
both internationally2 and in the provincial health care sectors in 
South Africa. Currently there are five full-time and three part-time 
dermatologists employed by the KwaZulu-Natal Provincial Health 
Department, all of whom are based in urban areas. Rural, and in some 
instances urban patients requiring dermatology diagnosis and clinical 
management are presently attended to by primary health providers 
in clinics and district hospitals, from where they may be referred to 
regional and tertiary centres. Referral is costly. The patient has to take 
time away from work and family and transport costs have to be borne 
by the patient or the Provincial Department of Health, which transports 
patients to the major centres by ambulance. 
As part of an outreach programme in KwaZulu-Natal, dermatologists 
fly to rural hospitals using the Red Cross Air Mercy Service every two 
to three months. While of great benefit to the patients and the district 
hospital doctors, this is a very ineffective way of utilising scarce human 
resources, as it takes a dermatologist out of hospital clinic practice for 
a day to see between 10 to 20 patients in the district. 
With the rapid advances and falling costs of information communication 
technology, telemedicine is a possible solution to some aspects of 
the problem. Teledermatology refers to the use of information and 
communication technology, such as the use of videoconferencing or 
the electronic transmission of digital images to enable the practice of 
diagnostic3 and clinical dermatology4 between participants separated 
by geographical distance. Telemedicine is not new, and many 
practitioners have unknowingly practised telemedicine when seeking 
or giving advice over the telephone or when faxing information to a 
colleague. Teledermatology is and has been practised in many parts of 
the world, including Norway, Finland, the USA, Canada, Australia, New 
Zealand, Northern Ireland, the Marshall Islands and the Greek island 
of Tilos.4,5,6,7,8,9 
Telemedicine services have broadly evolved into two categories: store 
and forward telemedicine, and synchronous or real-time telemedicine. 
Store and forward telemedicine, as its name implies, involves 
forwarding information which has already been saved in an electronic 
format to a consultant who reviews the case in his or her own time. For 
dermatology, this involves sending an e-mail or posting to a website 
the patient’s history and clinical information, with digital photographs of 
the lesions as an attachment. Synchronous or real-time telemedicine 
involves a live consultation with the consultant able to see and discuss 
the problem with the patient and the referrer. This usually involves 
some form of videoconference connection, to which can be added 
visual input from specialised instruments such as a dermascope, video 
camera or a document camera.   
Real-time videoconference teledermatology began in 1989 in 
Norway and was first reported in 1993.10 Subsequent literature has 
addressed issues of accuracy, reliability,11 confidence of diagnosis 
and management at a distance,12 patient13 and doctor satisfaction with 
teledermatology,14 image quality and the types of pathology best suited 
to teledermatology.4 The American Academy of Dermatologists has 
developed a position statement on the practice of teledermatology. 
To date there have been no reports of the practice of videoconferenced 
teledermatology in South Africa and no mention has been made in 
the international telemedicine literature of the potential difficulties 
associated with the practice of teledermatology in dark-skinned 
patients. The aim of this study was to initiate the use of integrated 
services digital network (ISDN) line-based videoconferencing for real-
time teledermatology in a South African setting, identify technological 
and operational issues and to assess patient and staff satisfaction and 
acceptance of the service. 
Methods
Patients were drawn from outpatients attending Port Shepstone 
Hospital in the months that the sessions were planned. The four 
selection criteria were i) that the patients had a dermatological problem; 
ii) the clinic doctor was uncertain of the diagnosis and management of 
the condition; iii) the patient would normally be transferred to Durban 
for a dermatological consultation; and iv) the patient was willing to 
take part in a teleconsultation. Patients were asked to return to Port 
Shepstone Hospital on the day of the consultation. 
Videoconferenced teledermatology sessions were held between Port 
Shepstone Hospital and the Nelson R Mandela School of Medicine 
in Durban, between 2003 and 2005. For the first nine consultation 
sessions, a Polycom 128 videoconference unit was used at the send 
site and a Polycom 383 unit at the receive site. At both sites, 80 cm 
colour monitors were used and communication was made using dial-
up ISDN telephone lines at 128 kbs-1. For the last two consultation 
sessions the videoconference unit at Port Shepstone was upgraded to 
a Sony 1P multi-send unit and for the final consultation the number of 
ISDN lines was increased to provide a bandwidth of 384 kbs-1. 
The receiving site conformed to accepted standards for lighting and 
room colour for telemedicine.15 The physical setting of the send site at 
Port Shepstone was substandard and the lighting was improved for 
the final three sessions. An auxiliary light was used at the send site to 
improve illumination of the lesion.  
The referring doctor explained the procedure of the teleconsultation 
to the patient and obtained consent. The referring doctor was 
present during the teleconsultation and presented the patient to 
the dermatologist who asked additional questions as necessary. 
The dermatological condition was then shown to the dermatologist.  
No peripheral devices were used. The video camera of the 
videoconference unit was used to show both the patient and the 
referring doctor at the beginning of the consultation, and the camera 
was then directed to and focussed on the areas of dermatological 
interest. The camera was fixed to the videoconference unit, but was 
able to incline within a vertical range of 45° and sweep up to 180° 
horizontally. In some cases this relative lack of freedom of camera 
movement necessitated positioning the patient so as to be able to see 
the lesion more easily. For the last three sessions, still images were 
captured by freezing the image on the screen when the dermatologist 
felt it was warranted. This provided an image free of possible motion 
artefacts. The dermatologist then offered a diagnosis, or differential 
diagnosis and management plan, which was implemented at the 
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referring hospital. In the event that the diagnosis was not obvious, or 
management necessitated admission to an academic hospital, the 
patient was transferred to King Edward Hospital in Durban for a face to 
face consultation.
A datasheet was completed for each consultation. The patient’s 
demographics, pertinent history, the referring doctor’s diagnosis or 
differential diagnosis, the dermatologist’s diagnosis or differential 
diagnosis, the management plan, and the duration of the consultation 
were recorded. In addition the patients’, referring doctors’ and 
dermatologist’s satisfaction with the teleconsultation were scored 
on a five-point scale. The referring doctor was also asked to rank 
the educational benefit of participating in the consultation with the 
dermatologist. 
Data are expressed as the mean and one standard deviation with the 
95% confidence interval. Between group comparison of means was 
by one-way analysis of variance with post hoc testing using the Tukey-
Kramer multiple comparisons test. Comparison of concordance of 
diagnoses was performed using a contingency table and the Chi-squared 
test and comparison of the transfer of patients was performed using 
Fisher’s exact test. Alpha was set at 5%. Statistical analysis was 
performed using GraphPad InStat software, Graphpad, San Diego, 
California.
Results 
Twelve teledermatology consultations were held, four in 2003, one 
in 2004 and seven in 2005. There were two medical officers who 
had a particular interest in dermatology who referred patients and 
one dermatologist was consulted. On two occasions a second 
junior dermatologist sat in as an observer. No patient declined 
teleconsultation. Sixty-nine patients participated in teleconsultations. 
Their average age was 40.5 + 19.1 years (95% CI: 35.9–45.0), range 
4 months to 80 years. There was a significant difference in ages 
between groups (ANOVA, p = 0.0003). The average age of the 34 
black patients, 32.0 + 17.7 years (95% CI: 26.0–38.1), was not different 
to that of the four coloured patients, namely 27.8 + 21.3 years (95% 
CI: 6.9–48.6), but was significantly younger than the 14 Indian patients, 
namely 48 + 15.6 years (95% CI: 39.8–56.2), p < 0.05, and the 17 
white patients, namely 53.6 + 14.2 years (95% CI: 46.9–60.4), p < 0.001. 
The coloured patients were also younger than the white patients (p < 0.05). 
Eight black and one coloured patient were under the age of 13 years. 
The average consultation time was 9 + 3 minutes, with a range of 3–20 
minutes. There was no difference between patient groups.
The outcome of the teleconsultations was that 12 patients (17.4%) 
were given either advice or treatment and were discharged after the 
consultation. Forty patients (58%) were prescribed treatment and 
were followed up at Port Shepstone Hospital, and 17 patients (24.6%) 
were transferred to Durban for further evaluation and management. 
Significantly more white patients warranted transfer to Durban than 
the other groups combined (Fishers’s exact test, p = 0.03, relative risk = 
1.562 (95% CI: 0.981–2.487)) (see Table I).
Table I: The outcome of the teleconsultations 
Black Coloured Indian White
Treat + discharge 6 (17.6%)
1 
(25.0%)
  4 
(28.6%)
     1 
(5.9%)
Follow up at PS 21 (61.8%)
2 
(50.0%)











(PS = Port Shepstone)
Based on the dermatologist’s diagnosis, the pathology was considered 
to be benign in 61 patients (88.4%), malignant in 6 (8.7%) and 
undetermined in 2 patients (2.9%). The referring doctor’s diagnosis 
or differential diagnosis was compared with that of the dermatologist. 
Overall there was concordance in the primary diagnosis in 47 cases 
(68.1%), in 2 cases the dermatologist confirmed one of the referring 
doctor’s differential diagnoses (2.9%), and in 11 cases (15.9%) the 
dermatologist made a definitive diagnosis that was different to any 
presented by the referring doctor. In eight instances (11.6%) the 
dermatologist could not make a definitive diagnosis and offered a 
differential diagnosis and in a further case (1.4%) there was agreement 
in that neither the referring doctor nor the dermatologist was able to 
make the diagnosis. The dermatologist was therefore unable to make 
a diagnosis in nine cases (13.0%). This occurred in three black (8.8%), 
one coloured (25%), two Indian (14.3%) and three white (17.6%) 
patients, and the inability to make a diagnosis was not significantly 
different between patient groups. For the nine patients under the age of 
13 years, there was 100% concordance between the diagnoses of the 
referring and consulting doctors.
For the purpose of analysis, and to determine which conditions 
might not be suitable for teledermatology, the conditions seen were 
categorised into groups (see Table II). In four of the eight cases that the 
dermatologist offered a differential diagnosis (two black, one coloured 
and one Indian patient) there was uncertainty between groups 1 and 
2. In three instances the differential diagnosis was that of seborrhoeic 
dermatitis or psoriasis and in the fourth case psoriasis or eczema. One 
white patient had a differential diagnosis of prurigo or solar keratosis 
from groups 2 and 8, and an Indian patient either polymorphic eruption, 
drug-induced solar dermatitis or SLE from groups 6, 7 and 8. Two 
white patients required skin biopsies to differentiate between a tumour 
and a connective tissue disease (groups 4 and 6) and between a 
melanoma and seborrhoeic dermatitis (groups 2 and 4).
Table II:  Range of conditions seen and grouped based on the dermatologist’s 
diagnosis
Group Conditions Total Concordance
1 Psoriasis, pityriasis rubra pilaris 11 10
2
Eczema (atopic eczema, 
seborrhoeic dermatitis, contact 
dermatitis)
14 12
3 Infections (viral, deep fungal infections, dermatophytes) 3 2
4 Tumours 4 3
5 Naevi 3 2
6 Connective tissue diseases 6 6
7 Drug reactions 2 1
8
Other (solar lentigo, seborrhoeic 
keratosis, vitiligo, macular 
amyloid, polymorphic eruption, 
pruritus, keratoderma, acne, skin 
nodules, ulcer, post-inflammatory 
hyperpigmentation, pityriasis rosea)
9 5
9 Autoimmume bullous diseases 2 1
10 Lichen planus 4 3
11 Unknown 3 3
The patients’, referring doctors’ and dermatologist’s level of satisfaction 
with the teleconsultation was scored on a five-point scale, where 1 
represented “very dissatisfied” and 5 represented “very satisfied”. The 
median scores for the patients, referring doctors and dermatologist 
was 4. To further assess satisfaction the number of times a score of 
4 (“satisfied”) or 5 (“very satisfied”) was given were added together 
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and expressed as a percentage. In total, 80.3% of the patients were 
satisfied with their consultation, the referring doctors rated 82.1% of the 
consultations as satisfactory, with the dermatologist satisfied 67.6% of 
the time. The differences were not statistically significant. Combining 
the scores of 1 (“very dissatisfied”) and 2 (“dissatisfied”), one patient 
was dissatisfied (1.5%) as was the referring doctor in the same case 
(1.5%). The dermatologist was dissatisfied 14.7% of the time. The 
referring doctor rated the educational value of the teleconsultation as 
good (40.6%) and very good (45.3% of the time).
Of the 17 patients who were referred to Durban for a face to face 
consultation, the median score for patients and the referring doctor was 
4 and for the dermatologist 3. Eleven patients (64.7%) were satisfied 
and none were dissatisfied. The referring doctor was satisfied on nine 
occasions (52.9%) and was not dissatisfied with any consultation. The 
dermatologist was satisfied with only six consultations (35.3%) and was 
dissatisfied 25% of the time. The difference was not significant. For the 
eight patients for whom a differential diagnosis was offered, the median 
satisfaction score of the dermatologist was 2.5, with zero satisfaction 
and 50% dissatisfaction. 
Discussion
This study reports on the experience of our attempt to introduce a 
videoconference-based, synchronous, teledermatology service. The 
main findings of this audit of the pilot sessions are that 52 of the 69 
patients (75.4%) were saved a 240 km round-trip to see the specialist 
dermatologist. In only one instance (1.4%) was the dermatologist not 
confident enough to make a diagnosis and in eight cases (11.6%) a 
differential rather than a definitive diagnosis was made. Patients were 
accepting of this approach to their management as were the referring 
doctors who also found the majority of sessions to be educational. 
There are several obvious shortcomings to the study. The first is 
that the teledermatology diagnosis made by the dermatologist is 
taken as being correct. The accuracy of diagnosis in telemedicine 
is defined as the degree of concordance between the telemedicine 
diagnosis and the diagnosis made in a face to face consultation.11 
Accuracy in videoconferenced teledermatology ranges from 57 to 
99%.16 There is, however, a degree of inter-observer variability among 
dermatologists in face to face consultations and Krupinsky suggests 
that the 85% agreement between face to face and teledermatology 
consultations parallels agreement rates for dermatologists using in-
person examination methods.17 The second shortcoming is that there 
are no patient follow-up data to determine whether the diagnosis and 
management plan was correct. The technology was improved during 
the course of the study and the effect of this has not been studied 
separately. There are as yet no outcome studies in teledermatology.11,17 
The failure of the dermatologist to make a definitive diagnosis in eight 
cases (11.6%) is in keeping with previously published figures which 
range from 3 to 11%.14,18,19,20 The cause of this may be technological. 
Videoconference image quality is dependent on the bandwidth 
used. Increasing the bandwidth reduces pixilation, motion delay and 
improves image resolution. Diagnostic accuracy has been shown 
to improve with increasing bandwidth, rising from 59% accuracy at 
128 kbs-1 to 80% at 384 kbs-1.19,21 At 128 kbs-1 image resolution is 
considered to be inadequate to diagnose isolated skin lesions, and it 
has been suggested that patients with potential melanomas should 
have a face to face consultation.4 Eczematous, acneiform14,18 and 
papulosquamous lesions16 have also been identified as being more 
difficult to diagnose. In this study, these conditions were also found to 
be difficult to diagnose by videoconferencing.
The level of patient satisfaction with the use of the technology may 
stem from the fact that many were saved a journey to Durban to 
see the dermatologist. This is in keeping with previous reports 
that between 85 and 100% of patients expressed satisfaction with 
videoconferenced teledermatology consultations,4,5,16,22 90% of patients 
were willing to have another teledermatology consultation,4 and 
more than half of the patients felt that teleconsultation was as good 
as a face to face consultation.23 Patients have, however, expressed 
concerns or reservations about privacy,24 their embarrassment of being 
photographed,25 the completeness  of information transmitted, and their 
anxiety about the use of technology.26 Some patients have felt that the 
technology hampers their expression of problems and concerns,27 and 
they are concerned about the lack of physical contact.13
The referring doctors in this study were satisfied with 82.1% of the 
teledermatology consultations and felt that they derived educational 
benefit from 85.9% of the consultations. It is possible that as early 
adopters of the technology these doctors may be biased by their 
enthusiasm for something new. In other studies, referring doctors 
have reported high levels of satisfaction with teledermatology,12 
the educational benefits derived,14,28 and noted the possibility of 
teamwork.29 In time, referring doctors have been found to make fewer 
referrals30 and manage more dermatology cases themselves.31
The level of satisfaction of the dermatologist was related to the 
adequacy of the images seen and the level of confidence in the 
diagnosis made. While satisfied 67.6% of the time, there was 
dissatisfaction in 14.7% of the cases. For the patients who were 
transferred for a face to face consultation, satisfaction dropped to 
35.3% while dissatisfaction rose to 25%. Where the dermatologist 
was uncertain and offered a differential diagnosis there was zero 
satisfaction and 50% dissatisfaction. When dermatologists’ satisfaction 
with a videoconferenced consultation has been low, there has 
been less concordance in the diagnosis made at the face to face 
consultation.12,16  It has been suggested that the patient should be 
referred for a face to face consultation when the dermatologist is not 
confident of the diagnosis,12 as was done in this study. 
A concern when planning the implementation of videoconferenced 
teledermatology was that diagnosis might prove to be more difficult in 
a predominantly dark-skinned population. In this limited series, skin 
colour did not appear to affect the ability of the dermatologists to make 
a diagnosis. This could be due to the dermatologist’s experience with 
dark-skinned patients, who constitute about 98% of the outpatients 
at the referral centre. Further studies are required to confirm that skin 
colour is not an impediment to synchronous teledermatology in the 
African setting. 
Several technical and logistical issues caused delays in the 
implementation of the service. In 2003, the videoconference unit at 
Port Shepstone was located in the radiology unit and was linked to an 
ultrasound machine. Four sessions were held at two-monthly intervals. 
While appropriate for tele-ultrasonography, the venue was small and 
the white walls made it difficult for the autofocus of the video camera in 
the unit to adjust to the brightness of the background. After the fourth 
session it was decided to move the equipment to another room with 
more space. The move of the ISDN lines proved to be problematic. 
There were delays in the line being moved and then one of the 
two lines was faulty, resulting in problems in either image or sound 
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quality. These were resolved and the service recommenced in mid 
2004. After only one session the referring doctor who had a particular 
interest in dermatology went on maternity leave and no other doctors 
took advantage of the service. After discussions with the staff at Port 
Shepstone the service was started again and has been running once a 
month with the involvement of more medical officers.  
The problems experienced highlight some of the issues relating 
to sustainability of telemedicine projects. Five criteria have been 
developed for assessing the potential for success of telemedicine: i) the 
programme must address a defined clinical problem; ii) organisational 
support must be evident; iii) the service must be accepted by 
physicians and patients; iv) costs and outcomes must be measured; 
and v) the operations must be self-supported or sustainable.5 The need 
for this teledermatology project and similar projects is clear, as there is 
a shortage of dermatologists in the state health sector. Organisational 
support can be divided into infrastructural support and administrative 
support. Infrastructural support at the distant sites is still problematical. 
The KwaZulu-Natal Department of Health has identified information 
technology “super users” at each of their hospitals. The super users 
are not IT professionals and do not have IT support as part of their job 
descriptions. This is not an ideal situation. Administrative support is 
present but needs to be developed to include electronic management 
of the patients’ records and patient bookings. In addition, more staff 
need to be trained in the use of the equipment at the referral hospitals 
and more dermatologists need to participate in this venture in order to 
build capacity.
It is common to find a new telemedicine service driven by an 
enthusiast, with the service failing when the enthusiast moves on or 
loses interest. This project has resulted in several doctors participating 
at the referring hospital and an acceptance by the receiving 
department to make teledermatology part of their normal practice. The 
doctors involved appear to be satisfied with the service, as are their 
patients. The costs and outcomes have not been measured and this 
will need to be addressed. The project is supported by the Provincial 
Department of Health and is currently sustainable.
The National Department of Health launched phase one of a series 
of pilot telemedicine projects in radiology, tele-ultrasonography and 
tele-ophthalmology in 1999.32,33 This project has not been expanded. 
The expected benefits of telemedicine are that it will improve access to 
care for patients in rural areas, provide high quality care at a distance, 
reduce patient travel, allow rural doctors access to specialists, thereby 
reducing their isolation, give peer support and provide education 
for rural doctors.4,7,11 This audit of a pilot teledermatology project by 
videoconference suggests that these benefits are obtainable in a South 
African setting. 
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